Friday, July 10, 2026

pharma · Hepatitis C Virus Infection · Chronic Hepatitis B

Gilead Sciences Ireland

Gilead Sciences Ireland patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

333 Lakeside Drive, Foster City, CA 94404, US HQ
1987 Founded
14,602 Employees
EMA registrant Type
Company details
Status
Public
HQ
333 Lakeside Drive, Foster City, CA 94404, US
Founded
1987
Employees
14,602
Programs
26
Drugs
17
Patents
0
Intelligence · Patents

Gilead Sciences Ireland patents

0 pharmaceutical patents indexed for Gilead Sciences Ireland. 0 expire within 24 months.

Gilead Sciences Ireland has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

No patents matched

Try a different expiry filter or check back as we index more USPTO records.

Frequently asked questions

How many patents does Gilead Sciences Ireland have?

0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Gilead Sciences Ireland patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.